China Pharma Holding (STU:XQJ) Institutional Ownership: 0.15% (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:XQJ China Pharma Holding Inc STU:XQJ
26 GF Score
Price €26.80
GF Value €4.95
! 3 Warning Signs
View Full Analysis

What is China Pharma Holding Institutional Ownership?

China Pharma Holding STU:XQJ 26 Institutional Ownership is 0.15% as of Aug. 01, 2026. GuruFocus rates STU:XQJ with a GF Score™ of 26/100 and a GF Value™ of €4.95. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, China Pharma Holding's institutional ownership is 0.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, China Pharma Holding's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, China Pharma Holding's Float Percentage Of Total Shares Outstanding is 68.72%.


China Pharma Holding Institutional Ownership Historical Data

* Premium members only.

The historical data trend for China Pharma Holding's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Pharma Holding Institutional Ownership Chart

China Pharma Holding Historical Data

The historical data trend for China Pharma Holding can be seen below:

2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31
Institutional Ownership 3.64 4.09 4.09 4.09 3.00 0.73 0.42 0.37 0.28 0.15
STU:XQJ
26GF Score
China Pharma Holding Inc STU:XQJ
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Pharma Holding Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.15% mean?
China Pharma Holding (STU:XQJ) has a Institutional Ownership of 0.15% as of Aug. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on China Pharma Holding and its competitors.
Is China Pharma Holding's Institutional Ownership too high?
China Pharma Holding's current Institutional Ownership is 0.15%. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's Institutional Ownership compare to INCR and TLPH?
China Pharma Holding's Institutional Ownership of 0.15% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on China Pharma Holding and its competitors. China Pharma Holding's current Institutional Ownership is 0.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current Institutional Ownership of 0.15%. The stock's GF Value™ is €4.95, compared to a current price of €26.80 — trading 441.4% above its estimated fair value. The current Institutional Ownership is 0.15%. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current Institutional Ownership is 0.15% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Pharma Holding (STU:XQJ) Overvalued in 2026?

Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued. The current stock price of €26.80 is trading 441.4% above its estimated GF Value™ of €4.95.

Key valuation signals for STU:XQJ:

  • Institutional Ownership: 0.15%
  • GF Value™: €4.95 vs. price of €26.80 (441.4% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Pharma Holding Business Description

Other Exchanges CPHI:USA
Address No. 17, Jinpan Road, Second Floor, Jiahai Building, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score

Get the complete analysis for STU:XQJ

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.80
Price
€4.95
GF Value